Exicure (XCUR) Interest & Investment Income (2019 - 2025)
Exicure (XCUR) reported Interest & Investment Income of $69000.0 for Q4 2025, up 137.93% quarter-over-quarter from $29000.0 in Q3 2025.
Exicure (XCUR) Interest & Investment Income (2019 - 2025) Analysis & Trends
Exicure has reported Interest & Investment Income for 7 years, with the latest figure at $69000.0 in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income changed N/A year-over-year to $69000.0; the trailing twelve-month figure through Mar 2026 stood at $102000.0 (up 1357.14% YoY), and the FY2025 full-year result was $107000.0, up 2040.0% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $69000.0, up from $29000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $88000.0 in Q1 2021, with the low at -$131000.0 in Q4 2021.
- Historically, Interest & Investment Income has averaged $13368.4 across 5 years, with a median of $5000.0 in 2025.
- Annual changes were most pronounced in 2021 — Interest & Investment Income sank 6650.0% — and 2025, when it jumped 2800.0%.
- Exicure's Interest & Investment Income stood at -$131000.0 in 2021, then surged by 154.2% to $71000.0 in 2022, then tumbled by 94.37% to $4000.0 in 2023, then slumped by 75.0% to $1000.0 in 2024, then surged by 6800.0% to $69000.0 in 2025.
- The last three Interest & Investment Income figures came in at $69000.0 (Q4 2025), $29000.0 (Q3 2025), and $4000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Exicure | 17.53 Mn | 14.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 17,000.00 |
| Dec 31, 2022 | 71,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | -131,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 43,000.00 |
| Mar 31, 2021 | 88,000.00 |
| Dec 31, 2020 | 2,000.00 |